wip These pages are work in progress. Please add comments if you want. If you have material to submit send them to me via admin@wmsurgeons.com

Search:     Advanced search
Browse by category:
Contact Us

Surgery in patients on anticoagulants

Author:Lala A.
on 12 Oct, 2007

Last edited by: Lala A. on 02 Nov, 2007
Add comment
Views: 898
Votes: 5
Comments: 0
Elective surgery in patients on warfarin:
Minor surgical procedures can be performed if INR < 2
Major surgical procedures require lowering of the INR to < 1.5. The need for continuing anticoagulation depends on their risk of thrombo-embolism.
 
High risk for thromboembolism: Such patients will need bridging anti-coagulation therapy
  • Older mechanical valve model (single-disk or ball-in-cage) in mitral position
  • Recently placed mechanical valve (< 3 months)
  • Atrial fibrillation plus mechanical heart valve in any position
  • Atrial fibrillation with history of cardioembolism
  • Recurrent (two or more) arterial or idiopathic venous thromboembolic events
  • Venous or arterial thromboembolism within the preceding 1–3 months
  • Known hypercoagulable state eg:
Ø      Protein C deficiency
Ø      Protein S deficiency
Ø      Antithrombin III deficiency
Ø      Homozygous factor V Leiden mutation
Ø      Antiphospholipid-antibody syndrome (1,2)
 
Intermediate risk for thromboembolism: bridging anticoagulation therapy may be required
  • Newer mechanical valve model (eg, St. Jude) in mitral position
  • Older mechanical valve model in aortic position
  • Cerebrovascular disease with multiple (two or more) strokes or transient ischemic attacks without
  • risk factors for cardiac embolism
  • Atrial fibrillation without a history of cardiac embolism but with multiple risks for cardiac embolism (eg, ejection fraction < 40%, diabetes, hypertension, nonrheumatic valvular heart disease, transmural myocardial infarction within preceding month)
  • Venous thromboembolism > 3–6 months ago
 
Low risk for thromboembolism: bridging anticoagulation therapy not advised
  • Atrial fibrillation without multiple risks for cardiac embolism
  • One remote venous thromboembolism (> 6 months ago)
  • Intrinsic cerebrovascular disease (such as carotid atherosclerosis) without recurrent strokes or transient ischemic attacks
  • Newer-model prosthetic valve in aortic position
 
Bridging anticoagulation therapy: Anticoagulation can be maintained either by heparin infusion or Low molecular weight heparin.
 
Bridging by using heparin: Discontinue warfarin 4-5 days before the day of surgery. Heparin should be started when the INR is < 2.5 in high risk patients (for example, in patients with mitral mechanical valves) and < 2.0 in patients with aortic mechanical valves. The activated partial thromboplastin time (aPTT) should be checked and prolonged to 1.5–2.0 of the control value. Heparin should be continued until six hours before surgery and resumed 6–12 hours after surgery, when surgically feasible. Oral anticoagulation can be resumed 1–2 days after surgery and once INR is > 2, heparin can be discontinued. (1,2,3)
 
Bridging by using low molecular weight heparin: Discontinue warfarin 4-5 days before the day of surgery. If INR< 2.5 in high risk patients (for example, in patients with mitral mechanical valves) and < 2.0 in patients with aortic mechanical valves, start low molecular weight heparin in therapeutic doses. (Enoxaparin 1.5 mg/kg subcutaneously every 24 hours. Continue low molecular weight heparin until 24hrs before procedure. Restart low molecular weight heparin 12­-24 hours after procedure and when haemostasis is established and restart warfarin night of or day after procedure. (1,2,3)
 
Emergency Surgery in patients on warfarin:
 
Urgent reversal of anticoagulation is required in patients with raised INR who need emergency surgery. Immediate reversal can be achieved by FFP transfusion, however for semi-urgent procedure (that can wait >12hrs) IV Vitamin K can be tried in first instance.
 
Fresh-frozen plasma(FFP) if given at the dose of 15 mls/kg body weight can reverse anticoagulation immediately without causing any resistance to warfarin. However, it is associated with the risks of transfusion, and its effects are short-lived.
After transfusion ensure that INR < 1.5 before starting surgery. If necessary more FPPs will be required. (1,2)
 
Vitamin K: smaller doses of IV vit K (1.25 – 2.5 mg) should be used to avoid postoperative resistance to warfarin. One study found that the median time to reversal of anticoagulation after a 1-mg IV vitamin K was approximately 27 hours (range 0.7–147 hours). (1,2)
 
  1. cleveland clinic guidelines on reversal of warfarin 2003; free dowload
 
  1. Anticoagulation for patients who need surgery; Cliv Clin J Med 2006.pdf (free dowload)
 
  1. reversal of warfarin: australian guidelines.pdf (free download)
 
  1. ABC of antithromboti therapy: BMJ 2003 review (free download)
 
  1. Anticoagulation in valvar heart disease;Heart 2000 (access via athens)
Others in this Category
document Massive transfusion
document Disseminated intravascular coagulation (DIC)
document Pathophysiological of pnemoperitoneum in Laparoscopic surgery
document Medications to discontinue before surgery?
document Management of Atrial Fibrillation
document How would you investigate a patient with Iron deficiency anaemia?



RSS